Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 17, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that EuroIntervention, the official journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI), has published online a peer-reviewed study announcing the outcomes of patients undergoing Neovasc Reducer™ ("Reducer") implantation in the Company's REDUCER-I trial. The article, entitled...
2020-12-17 7:00 AM EST
Neovasc Announces First Neovasc Reducer(TM) Implants in France
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 15, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has completed the first three Neovasc Reducer™ ("Reducer") implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina.The implants were conducted by Prof. Martine Gilard, Director of Interventional...
2020-12-15 7:00 AM EST
Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 14, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed...
2020-12-14 6:40 PM EST
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 10, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") , announced today that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is not in compliance with the minimum market value requirement set forth in Nasdaq Rules for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(2) requires...
2020-12-10 5:56 PM EST
Neovasc Announces Closing of US$6.1 Million Registered Direct Offering Priced At-The-Market
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 10, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has closed its previously announced registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq") rules of an aggregate of 6,230,803 common shares at a price of US$0.9801 per common share. Aggregate gross proceeds to the Company were approximately US$6.1 million,...
2020-12-10 4:40 PM EST
Neovasc Announces US$6.1 Million Registered Direct Offering Priced At-the-Market
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 8, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 6,230,803 common shares at a purchase price of US$0.9801 per common share in a registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq")...
2020-12-08 9:00 AM EST
Neovasc Announces Participation in Noble Capital Markets Virtual Road Show Series
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - December 1, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), today announced their participation in Noble Capital Markets' Virtual Road Show Series, presented by Channelchek, scheduled for December 8, 2020.The virtual road show will feature a corporate presentation from Neovasc President & CEO, Fred Colen, followed by a Q & A session proctored by Noble Biotechnology Research Analyst Ahu Demir, Ph.D.,...
2020-12-01 4:30 PM EST
Neovasc to Participate in Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum
Vancouver, British Columbia--(Newsfile Corp. - November 16, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020. Fred Colen, Neovasc's President and Chief Executive Officer, will deliver a presentation at 11:00 am EST. Mr. Colen will also be joined by Chief Financial Officer Chris Clark, and Chief Operating Officer Bill Little, for...
2020-11-16 4:46 PM EST
Neovasc Announces Third Quarter Financial Results
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 5, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today reported financial results for the third quarter ended September 30, 2020.Third Quarter HighlightsGrew revenue 25% year-over-year in the quarter.Implants increased...
2020-11-05 4:05 PM EST
Neovasc Announces FDA Advisory Panel Result on Neovasc Reducer(TM) Medical Device for the Treatment of Refractory Angina
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - October 28, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that the United States Food and Drug Administration's (FDA's) Circulatory System Devices Advisory Panel voted 14 to 4 "in favor" that the Neovasc Reducer™ is safe when used as intended, and voted 1 to 17 "against" on the issue of a reasonable assurance of effectiveness. The third vote was 13 to 3 "against" (2 abstained) on...
2020-10-28 7:00 AM EDT
Neovasc to Report Third Quarter Financial Results on November 5, 2020
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - October 22, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) today announced that it will report financial results for the quarter ended September 30, 2020 after the market close on November 5, 2020. Neovasc President and Chief Executive Officer Fred Colen, and Chief Financial Officer Chris Clark will host a conference call to review the company's results at 4:30 PM Eastern Time.Interested parties may access the conference call by...
2020-10-22 9:00 AM EDT
Neovasc to Sponsor Symposium on Treating Patients with Refractory Angina at TCT Connect 2020
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - October 13, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that it will sponsor a symposium entitled "Unmet Need in Treating Patients With Refractory Angina" at the 2020 TCT Connect Online Conference, taking place October 14-18, 2020.The training session will be available via the TCT Connect e-satellite for registered participants beginning Friday, October 16, at 7 AM EDT. The session...
2020-10-13 8:00 AM EDT
Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - September 8, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today announced that its management team will be participating in the 22nd Annual H.C. Wainwright Global Investment Conference on September 14-16, 2020. Fred Colen,...
2020-09-08 5:10 PM EDT
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on September 3, 2020 in Vancouver, B.C. (the "Meeting").At the Meeting, the shareholders of the Company (the "Shareholders") re-elected board members Steven Rubin, Paul Geyer, Doug Janzen, Norman Radow, Alexei Marko and Fred Colen to serve...
2020-09-03 4:41 PM EDT
Neovasc Announces Partial Prepayment of Convertible Debenture
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 17, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that Strul Medical Group LLC ("SMG") exercised 501,000 of the remaining 1,149,910 common share purchase warrants (the "May Warrants") issued pursuant to a Securities Purchase Agreement dated May 26, 2020 at an exercise price of US$2.634 per May Warrant for aggregate exercise proceeds to the Company of US$1,319,634.00 (the...
2020-08-17 9:00 AM EDT
Neovasc Provides Corporate Update
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 13, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), today provided a corporate update on progress towards its value creation strategies. Fred Colen, Chief Executive Officer of Neovasc, commented, "We are pleased to provide a corporate update to our investors as we have made meaningful progress against our value creation strategies. We have clear line of site to important milestones across each...
2020-08-13 9:00 AM EDT
Neovasc Announces Closing of US$12.6 Million Registered Direct Offering Priced At-The-Market
Vancouver, British Columbia--(Newsfile Corp. - August 12, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has closed its previously announced registered direct offering (the "Offering") priced at-the-market under the Nasdaq rules of an aggregate of 4,532,772 common shares at a purchase price of US$2.77575 per common share for aggregate gross proceeds to the Company of approximately US$12.6 million, before deducting placement agent's fees...
2020-08-12 2:41 PM EDT
Neovasc Announces US$12.6 Million Registered Direct Offering Priced At-the-Market
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 4,532,772 common shares at a purchase price of US$2.77575 per common share in a registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq") rules for aggregate...
2020-08-10 8:00 AM EDT
Neovasc Announces Second Quarter Financial Results
British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 6, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today reported financial results for the second quarter ended June 30, 2020.Second Quarter HighlightsFollowing a COVID-related slowdown, experienced a sharp rebound in...
2020-08-06 4:05 PM EDT
Neovasc Reducer(TM) Featured In Germany's Second Largest National Newspaper
Minnesota and Frankfurt, Germany--(Newsfile Corp. - July 24, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that the Neovasc Reducer™ (the "Reducer") was featured in a supplement titled: "Volkskrankheiten" or "Common Diseases" in Frankfurter Allgemeine Zeitung (FAZ), the second largest national newspaper by circulation in Germany. The supplement will be mailed to subscribers, reaching an estimated audience of almost 500,000 and should be...
2020-07-24 9:57 AM EDT